Exploration of PCNE Classification System in Practice in Physician-and Pharmacist-Managed Clinic for Interstitial Lung Diseases
10.3870/j.issn.1004-0781.2023.12.020
- VernacularTitle:欧洲医药保健网分类系统在间质性肺疾病医药联合门诊中的实践
- Author:
Xiulan LIU
1
;
Huilan ZHANG
;
Juan LI
Author Information
1. 华中科技大学同济医学院附属同济医院药学部,武汉 430030
- Keywords:
Pharmaceutical care network Europe classification system;
Physician-and pharmacist-managed clinic;
Interstitial lung disease;
Drug related problems;
Rational drug use
- From:
Herald of Medicine
2023;42(12):1862-1867
- CountryChina
- Language:Chinese
-
Abstract:
Objective To promote the pharmacist's ability to identify and resolve drug-related problems(DRPs)in Physician-and pharmacist-managed clinic of interstitial lung disease using pharmaceutical care network Europe(PCNE)classification system.Methods Patients of physician-and pharmacist-managed clinic from February 1,2022 to February 1,2023 were included.Problems,causes,intervention types,intervention acceptability,and solution state of DRPs were analyzed using the PCNE classification system.Results A total of 128 patients were included and 178 DRPs were identified,with an average of 1.39 DRPs per patient.The main types of problems were effectiveness(127 cases,71.35%)and safety(39 cases,21.91%);The main causes classification were patient-related(85 cases,47.75%),drug selection(30 cases,16.85%)and dose selection(27 cases,15.17%);The main intervention type was patient-level(176 cases,54.32%).A total of 243 interventions were provided to physicians and patients by pharmacists,in which 231 interventions were accepted with the overall acceptance rate of 95.06%.Ultimately,152(85.39%)DRPs were resolved.Conclusion The PCNE classification system is helpful to improve the efficiency of DRP recognition and resolution in the joint outpatient clinic,promote the standardization,convenience,and precision of the pharmaceutical care model,and improve the rationality,safety,and effectiveness of patients'drug use.
